Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni Cathomen

Showing results (111-120 of 172) with videos related to

Pageof 18
Sort By:
Genome Biology|February 3, 2026
Functional correction and genome integrity with duplex base editing of β-thalassemic hematopoietic stem cellsNikoletta Y Papaioannou, Petros Patsali, Julia Klermund, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 9, 2024
On- and off-target effects of paired CRISPR-Cas nickase in primary human cellsJulia Klermund, Manuel Rhiel, Thomas Kocher, et al.
Nucleic Acids Research|April 18, 2023
A novel Cas9 fusion protein promotes targeted genome editing with reduced mutational burden in primary human cellsAntonio Carusillo, Sibtain Haider, Raul Schäfer, et al.
European Urology Oncology|April 17, 2023
Adaptive Immunity in Genitourinary CancersMadhuri Koti, Trinity Bivalacqua, Peter C Black, et al.
Cell Communication and Signaling : CCS|July 9, 2024
Hypoxic extracellular vesicles from hiPSCs protect cardiomyocytes from oxidative damage by transferring antioxidant proteins and enhancing Akt/Erk/NRF2 signalingSylwia Bobis-Wozowicz, Milena Paw, Michał Sarna, et al.
Frontiers in Genome Editing|March 27, 2023
High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on <i>in vitro</i> mRNA synthesisNikoletta Y Papaioannou, Petros Patsali, Basma Naiisseh, et al.
Biotechnology Journal|October 26, 2020
Preclinical Evaluation of a Novel TALEN Targeting CCR5 Confirms Efficacy and Safety in Conferring Resistance to HIV-1 InfectionMarianna Romito, Alexandre Juillerat, Yik Lim Kok, et al.
Plos Genetics|May 23, 2015
Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease ModelShamim H Rahman, Johannes Kuehle, Christian Reimann, et al.
Scientific Reports|April 26, 2020
TALEN mediated gene editing in a mouse model of Fanconi anemiaMaria José Pino-Barrio, Yari Giménez, Mariela Villanueva, et al.
Haematologica|April 21, 2019
Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas-and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cellsPetros Patsali, Giandomenico Turchiano, Panayiota Papasavva, et al.
Pageof 18

Showing results (111-120 of 172) with videos related to

Sort By:
Pageof 18
Genome Biology|February 3, 2026
Functional correction and genome integrity with duplex base editing of β-thalassemic hematopoietic stem cellsNikoletta Y Papaioannou, Petros Patsali, Julia Klermund, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 9, 2024
On- and off-target effects of paired CRISPR-Cas nickase in primary human cellsJulia Klermund, Manuel Rhiel, Thomas Kocher, et al.
Nucleic Acids Research|April 18, 2023
A novel Cas9 fusion protein promotes targeted genome editing with reduced mutational burden in primary human cellsAntonio Carusillo, Sibtain Haider, Raul Schäfer, et al.
European Urology Oncology|April 17, 2023
Adaptive Immunity in Genitourinary CancersMadhuri Koti, Trinity Bivalacqua, Peter C Black, et al.
Cell Communication and Signaling : CCS|July 9, 2024
Hypoxic extracellular vesicles from hiPSCs protect cardiomyocytes from oxidative damage by transferring antioxidant proteins and enhancing Akt/Erk/NRF2 signalingSylwia Bobis-Wozowicz, Milena Paw, Michał Sarna, et al.
Frontiers in Genome Editing|March 27, 2023
High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on <i>in vitro</i> mRNA synthesisNikoletta Y Papaioannou, Petros Patsali, Basma Naiisseh, et al.
Biotechnology Journal|October 26, 2020
Preclinical Evaluation of a Novel TALEN Targeting CCR5 Confirms Efficacy and Safety in Conferring Resistance to HIV-1 InfectionMarianna Romito, Alexandre Juillerat, Yik Lim Kok, et al.
Plos Genetics|May 23, 2015
Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease ModelShamim H Rahman, Johannes Kuehle, Christian Reimann, et al.
Scientific Reports|April 26, 2020
TALEN mediated gene editing in a mouse model of Fanconi anemiaMaria José Pino-Barrio, Yari Giménez, Mariela Villanueva, et al.
Haematologica|April 21, 2019
Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas-and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cellsPetros Patsali, Giandomenico Turchiano, Panayiota Papasavva, et al.
Pageof 18